HIPAA-compliant telehealth service improves access to medical marijuana

Cara Livernois | | Health Exec | Telehealth

Patients may be able to receive medical marijuana delivered via a new telehealth platform provided by Columbia Care. The New York-based company's HIPAA-compliant video conferencing software will provide homebound patients a secure delivery service for medication.

The combination of telehealth and delivery services provides patients with a video conferencing session with a pharmacist as well as the ability to order medication for home delivery. Currently with 450 users, the platform aims to expand to other states to give every patient the opportunity to receive their medication in a secure and efficient manner.

“The plan is to pilot services in New York, and if they’re successful, we can expand to other states,” said Nick Vita, CEO of Columbia Care.

Read the full story below:

HIPAA-Compliant Online Chats For Medical Marijuana Come to New York -- Deliveri…

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Amazon One Medical sued after patient prescribed inhaler dies in ER
DEA, HHS extend telehealth controlled substance prescription rule
Association of 300 telehealth groups urges Congress to extend COVID-era rules
Eli Lilly releases cheaper, single-use vials of weight loss drug
Walmart sells virtual care business to Fabric
AMA will aggressively support permanent telemedicine reimbursement

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.